Adipocyte - breast, donor1.CNhs11051.11376-118A8 | 0.00 | 0.00 |
Adipocyte - breast, donor2.CNhs11969.11327-117E4 | 192.69 | 20.77 |
Adipocyte - omental, donor1.CNhs11054.11473-119C6 | 154.77 | 18.47 |
Adipocyte - omental, donor2.CNhs12067.11474-119C7 | 190.14 | 28.02 |
Adipocyte - omental, donor3.CNhs12068.11475-119C8 | 208.73 | 28.61 |
Adipocyte - perirenal, donor1.CNhs12069.11476-119C9 | 171.85 | 18.32 |
Adipocyte - subcutaneous, donor1.CNhs12494.11259-116F8 | 268.50 | 40.53 |
Adipocyte - subcutaneous, donor2.CNhs11371.11336-117F4 | 223.63 | 10.74 |
Adipocyte - subcutaneous, donor3.CNhs12017.11408-118E4 | 298.54 | 26.90 |
Alveolar Epithelial Cells, donor1.CNhs11325.11510-119G7 | 162.92 | 17.69 |
Alveolar Epithelial Cells, donor2.CNhs12084.11590-120G6 | 652.44 | 88.62 |
Amniotic Epithelial Cells, donor1.CNhs11341.11533-120A3 | 133.69 | 19.00 |
Amniotic Epithelial Cells, donor3.CNhs12125.11694-123A2 | 204.16 | 31.65 |
Anulus Pulposus Cell, donor1.CNhs10876.11248-116E6 | 169.44 | 24.38 |
Anulus Pulposus Cell, donor2.CNhs12064.11463-119B5 | 234.30 | 31.81 |
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1).CNhs13339.12642-134G5 | 147.91 | 12.77 |
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2).CNhs13358.12740-135I4 | 154.89 | 12.66 |
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31).CNhs13349.12652-134H6 | 162.13 | 15.34 |
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32).CNhs13369.12750-136A5 | 182.97 | 15.13 |
Astrocyte - cerebellum, donor1.CNhs11321.11500-119F6 | 168.43 | 26.84 |
Astrocyte - cerebellum, donor2.CNhs12081.11580-120F5 | 239.29 | 54.88 |
Astrocyte - cerebellum, donor3.CNhs12117.11661-122F5 | 301.54 | 42.94 |
Astrocyte - cerebral cortex, donor1.CNhs10864.11235-116D2 | 96.18 | 13.74 |
Astrocyte - cerebral cortex, donor2.CNhs11960.11316-117D2 | 124.28 | 19.85 |
Astrocyte - cerebral cortex, donor3.CNhs12005.11392-118C6 | 117.38 | 16.70 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1.CNhs12331.10821-111C2 | 96.05 | 15.51 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2.CNhs12332.10822-111C3 | 89.49 | 16.26 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3.CNhs12333.10823-111C4 | 83.59 | 12.28 |
Basophils, donor1.CNhs12546.12241-129G9 | 86.93 | 12.59 |
Basophils, donor2.CNhs12563.12242-129H1 | 62.56 | 7.68 |
Basophils, donor3.CNhs12575.12243-129H2 | 82.05 | 12.69 |
Bronchial Epithelial Cell, donor4.CNhs12054.11453-119A4 | 334.67 | 52.41 |
Bronchial Epithelial Cell, donor5.CNhs12058.11457-119A8 | 398.19 | 51.51 |
Bronchial Epithelial Cell, donor6.CNhs12062.11461-119B3 | 318.73 | 37.71 |
Burkitt's lymphoma cell line:DAUDI.CNhs10739.10422-106C8 | 113.88 | 15.65 |
Burkitt's lymphoma cell line:RAJI.CNhs11268.10476-106I8 | 78.34 | 9.38 |
CD133+ stem cells - adult bone marrow derived, pool1.CNhs12552.12224-129F1 | 89.55 | 20.26 |
CD14+ Monocytes, donor1.CNhs10852.11224-116B9 | 72.02 | 15.51 |
CD14+ Monocytes, donor2.CNhs11954.11305-117B9 | 90.04 | 13.44 |
CD14+ Monocytes, donor3.CNhs11997.11381-118B4 | 95.70 | 16.06 |
CD14+ monocyte derived endothelial progenitor cells, donor1.CNhs10858.11229-116C5 | 69.64 | 21.50 |
CD14+ monocyte derived endothelial progenitor cells, donor2.CNhs11897.11310-117C5 | 78.38 | 16.19 |
CD14+ monocyte derived endothelial progenitor cells, donor3.CNhs11904.11386-118B9 | 59.76 | 13.65 |
CD14+ monocytes - mock treated, donor1.CNhs13468.11863-125A9 | 84.77 | 14.25 |
CD14+ monocytes - mock treated, donor2.CNhs13484.11873-125C1 | 79.73 | 6.80 |
CD14+ monocytes - mock treated, donor3.CNhs13491.11883-125D2 | 85.63 | 7.52 |
CD14+ monocytes - treated with B-glucan, donor1.CNhs13474.11869-125B6 | 87.86 | 10.92 |
CD14+ monocytes - treated with B-glucan, donor2.CNhs13489.11879-125C7 | 87.58 | 6.58 |
CD14+ monocytes - treated with B-glucan, donor3.CNhs13495.11889-125D8 | 71.23 | 5.27 |
CD14+ monocytes - treated with BCG, donor1.CNhs13465.11860-125A6 | 82.28 | 12.66 |
CD14+ monocytes - treated with BCG, donor2.CNhs13475.11870-125B7 | 83.25 | 8.71 |
CD14+ monocytes - treated with BCG, donor3.CNhs13543.11880-125C8 | 58.17 | 6.15 |
CD14+ monocytes - treated with Candida, donor1.CNhs13473.11868-125B5 | 83.08 | 11.03 |
CD14+ monocytes - treated with Candida, donor2.CNhs13488.11878-125C6 | 74.88 | 9.04 |
CD14+ monocytes - treated with Candida, donor3.CNhs13494.11888-125D7 | 94.80 | 9.48 |
CD14+ monocytes - treated with Cryptococcus, donor1.CNhs13472.11867-125B4 | 95.63 | 11.11 |
CD14+ monocytes - treated with Cryptococcus, donor2.CNhs13487.11877-125C5 | 77.51 | 7.64 |
CD14+ monocytes - treated with Cryptococcus, donor3.CNhs13546.11887-125D6 | 56.41 | 3.37 |
CD14+ monocytes - treated with Group A streptococci, donor1.CNhs13469.11864-125B1 | 78.05 | 11.33 |
CD14+ monocytes - treated with Group A streptococci, donor2.CNhs13532.11874-125C2 | 59.37 | 8.67 |
CD14+ monocytes - treated with Group A streptococci, donor3.CNhs13492.11884-125D3 | 69.05 | 10.23 |
CD14+ monocytes - treated with IFN + N-hexane, donor1.CNhs13466.11861-125A7 | 73.23 | 11.87 |
CD14+ monocytes - treated with IFN + N-hexane, donor2.CNhs13476.11871-125B8 | 79.59 | 11.77 |
CD14+ monocytes - treated with IFN + N-hexane, donor3.CNhs13490.11881-125C9 | 75.02 | 7.25 |
CD14+ monocytes - treated with Salmonella, donor1.CNhs13471.11866-125B3 | 79.23 | 9.58 |
CD14+ monocytes - treated with Salmonella, donor2.CNhs13485.11876-125C4 | 80.00 | 10.21 |
CD14+ monocytes - treated with Salmonella, donor3.CNhs13493.11886-125D5 | 71.62 | 6.85 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1.CNhs13467.11862-125A8 | 90.95 | 11.05 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2.CNhs13483.11872-125B9 | 86.04 | 7.82 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3.CNhs13544.11882-125D1 | 55.17 | 7.17 |
CD14+ monocytes - treated with lipopolysaccharide, donor1.CNhs13470.11865-125B2 | 86.57 | 9.69 |
CD14+ monocytes - treated with lipopolysaccharide, donor2.CNhs13533.11875-125C3 | 61.50 | 5.89 |
CD14+ monocytes - treated with lipopolysaccharide, donor3.CNhs13545.11885-125D4 | 50.32 | 3.80 |
CD14+CD16+ Monocytes, donor1.CNhs13541.11789-124B7 | 90.63 | 12.25 |
CD14+CD16+ Monocytes, donor2.CNhs13208.11801-124D1 | 95.03 | 14.03 |
CD14+CD16+ Monocytes, donor3.CNhs13549.11912-125G4 | 94.56 | 7.97 |
CD14+CD16- Monocytes, donor1.CNhs13224.11788-124B6 | 84.02 | 20.33 |
CD14+CD16- Monocytes, donor2.CNhs13216.11799-124C8 | 91.61 | 16.07 |
CD14+CD16- Monocytes, donor3.CNhs13540.11910-125G2 | 54.49 | 8.04 |
CD14-CD16+ Monocytes, donor1.CNhs13229.11790-124B8 | 102.60 | 16.82 |
CD14-CD16+ Monocytes, donor2.CNhs13207.11800-124C9 | 105.23 | 13.92 |
CD14-CD16+ Monocytes, donor3.CNhs13548.11911-125G3 | 90.60 | 8.22 |
CD19+ B Cells (pluriselect), donor090309, donation1.CNhs12177.12189-129B2 | 98.56 | 19.36 |
CD19+ B Cells (pluriselect), donor090309, donation2.CNhs12179.12194-129B7 | 91.21 | 10.92 |
CD19+ B Cells (pluriselect), donor090309, donation3.CNhs12181.12199-129C3 | 99.63 | 19.57 |
CD19+ B Cells (pluriselect), donor090325, donation1.CNhs12531.12151-128F9 | 89.61 | 11.95 |
CD19+ B Cells (pluriselect), donor090325, donation2.CNhs12175.12174-128I5 | 96.10 | 23.22 |
CD19+ B Cells (pluriselect), donor090612, donation1.CNhs12183.12204-129C8 | 93.68 | 12.07 |
CD19+ B Cells (pluriselect), donor090612, donation2.CNhs12185.12209-129D4 | 94.53 | 15.87 |
CD19+ B Cells (pluriselect), donor090612, donation3.CNhs12188.12214-129D9 | 91.59 | 5.72 |
CD19+ B Cells, donor1.CNhs12343.11544-120B5 | 113.27 | 16.51 |
CD19+ B Cells, donor2.CNhs12352.11624-122B4 | 94.55 | 11.16 |
CD19+ B Cells, donor3.CNhs12354.11705-123B4 | 110.09 | 13.00 |
CD34+ Progenitors, donor1.CNhs13227.11545-120B6 | 95.16 | 17.18 |
CD34+ Progenitors, donor2.CNhs12205.11625-122B5 | 82.96 | 11.21 |
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1.CNhs12588.12225-129F2 | 112.99 | 20.54 |
CD4+ T Cells, donor1.CNhs10853.11225-116C1 | 57.64 | 9.05 |
CD4+ T Cells, donor2.CNhs11955.11306-117C1 | 92.75 | 12.18 |
CD4+ T Cells, donor3.CNhs11998.11382-118B5 | 92.52 | 11.31 |
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1.CNhs13203.11793-124C2 | 83.09 | 10.20 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor1.CNhs13238.11780-124A7 | 82.13 | 10.10 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor2.CNhs13235.11796-124C5 | 81.43 | 14.20 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor3.CNhs13513.11907-125F8 | 103.26 | 9.74 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1.CNhs13204.11794-124C3 | 106.17 | 13.26 |
CD4+CD25+CD45RA- memory regulatory T cells, donor1.CNhs13195.11782-124A9 | 110.48 | 12.08 |
CD4+CD25+CD45RA- memory regulatory T cells, donor2.CNhs13206.11797-124C6 | 102.57 | 13.29 |
CD4+CD25+CD45RA- memory regulatory T cells, donor3.CNhs13538.11908-125F9 | 55.24 | 4.06 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2.CNhs13811.11916-125G8 | 135.65 | 19.21 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3.CNhs13812.11920-125H3 | 124.08 | 18.73 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2.CNhs13813.11913-125G5 | 147.34 | 24.83 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3.CNhs13814.11917-125G9 | 147.85 | 18.79 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1.CNhs13202.11791-124B9 | 102.30 | 11.88 |
CD4+CD25-CD45RA+ naive conventional T cells, donor1.CNhs13223.11784-124B2 | 79.19 | 15.13 |
CD4+CD25-CD45RA+ naive conventional T cells, donor2.CNhs13205.11795-124C4 | 74.64 | 8.83 |
CD4+CD25-CD45RA+ naive conventional T cells, donor3.CNhs13512.11906-125F7 | 76.31 | 7.32 |
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1.CNhs13215.11792-124C1 | 103.68 | 12.58 |
CD4+CD25-CD45RA- memory conventional T cells, donor1.CNhs13239.11786-124B4 | 84.31 | 12.65 |
CD4+CD25-CD45RA- memory conventional T cells, donor2.CNhs13237.11798-124C7 | 85.56 | 17.87 |
CD4+CD25-CD45RA- memory conventional T cells, donor3.CNhs13539.11909-125G1 | 50.60 | 4.30 |
CD8+ T Cells (pluriselect), donor090309, donation1.CNhs12176.12186-129A8 | 90.79 | 16.88 |
CD8+ T Cells (pluriselect), donor090309, donation2.CNhs12178.12191-129B4 | 94.41 | 14.97 |
CD8+ T Cells (pluriselect), donor090309, donation3.CNhs12180.12196-129B9 | 88.39 | 17.11 |
CD8+ T Cells (pluriselect), donor090325, donation1.CNhs12201.12148-128F6 | 74.84 | 12.35 |
CD8+ T Cells (pluriselect), donor090325, donation2.CNhs12199.12171-128I2 | 71.80 | 9.60 |
CD8+ T Cells (pluriselect), donor090612, donation1.CNhs12182.12201-129C5 | 88.70 | 12.49 |
CD8+ T Cells (pluriselect), donor090612, donation2.CNhs12184.12206-129D1 | 88.55 | 14.92 |
CD8+ T Cells (pluriselect), donor090612, donation3.CNhs12187.12211-129D6 | 102.64 | 15.60 |
CD8+ T Cells, donor1.CNhs10854.11226-116C2 | 82.66 | 13.31 |
CD8+ T Cells, donor2.CNhs11956.11307-117C2 | 103.23 | 11.23 |
CD8+ T Cells, donor3.CNhs11999.11383-118B6 | 98.34 | 9.70 |
Cardiac Myocyte, donor1.CNhs12341.11525-119I4 | 329.14 | 19.50 |
Cardiac Myocyte, donor2.CNhs12350.11605-120I3 | 232.06 | 26.16 |
Cardiac Myocyte, donor3.CNhs12571.11686-122I3 | 149.73 | 15.22 |
Chondrocyte - de diff, donor1.CNhs11923.11261-116G1 | 194.09 | 18.43 |
Chondrocyte - de diff, donor2.CNhs11372.11338-117F6 | 215.58 | 11.53 |
Chondrocyte - de diff, donor3.CNhs12020.11410-118E6 | 288.39 | 26.80 |
Chondrocyte - re diff, donor2.CNhs11373.11339-117F7 | 62.03 | 0.00 |
Chondrocyte - re diff, donor3.CNhs12021.11411-118E7 | 214.12 | 17.03 |
Ciliary Epithelial Cells, donor1.CNhs10871.11242-116D9 | 108.15 | 18.62 |
Ciliary Epithelial Cells, donor2.CNhs11966.11323-117D9 | 167.85 | 23.73 |
Ciliary Epithelial Cells, donor3.CNhs12009.11399-118D4 | 144.40 | 21.17 |
Clontech Human Universal Reference Total RNA, pool1.CNhs10608.10000-101A1 | 81.93 | 19.32 |
Corneal Epithelial Cells, donor1.CNhs11336.11526-119I5 | 208.38 | 28.42 |
Corneal Epithelial Cells, donor3.CNhs12123.11687-122I4 | 186.88 | 25.21 |
Dendritic Cells - monocyte immature derived, donor1, tech_rep1.CNhs10855.11227-116C3 | 49.01 | 19.15 |
Dendritic Cells - monocyte immature derived, donor1, tech_rep2.CNhs11062.11227-116C3 | 58.86 | 18.11 |
Dendritic Cells - monocyte immature derived, donor3.CNhs12000.11384-118B7 | 60.10 | 18.75 |
Dendritic Cells - plasmacytoid, donor1.CNhs10857.11228-116C4 | 58.19 | 10.97 |
Dendritic Cells - plasmacytoid, donor2.CNhs12196.11309-117C4 | 52.62 | 5.72 |
Dendritic Cells - plasmacytoid, donor3.CNhs12200.11385-118B8 | 52.00 | 8.54 |
Endothelial Cells - Aortic, donor0.CNhs10837.11207-116A1 | 158.21 | 32.80 |
Endothelial Cells - Aortic, donor1.CNhs12495.11263-116G3 | 277.86 | 23.23 |
Endothelial Cells - Aortic, donor2.CNhs11375.11340-117F8 | 158.99 | 24.30 |
Endothelial Cells - Aortic, donor3.CNhs12022.11412-118E8 | 305.83 | 29.96 |
Endothelial Cells - Artery, donor1.CNhs12496.11264-116G4 | 268.48 | 35.24 |
Endothelial Cells - Artery, donor2.CNhs11977.11341-117F9 | 256.13 | 39.89 |
Endothelial Cells - Artery, donor3.CNhs12023.11413-118E9 | 232.82 | 32.19 |
Endothelial Cells - Lymphatic, donor1.CNhs10865.11236-116D3 | 105.18 | 23.52 |
Endothelial Cells - Lymphatic, donor2.CNhs11901.11317-117D3 | 135.90 | 14.59 |
Endothelial Cells - Lymphatic, donor3.CNhs11906.11393-118C7 | 70.29 | 10.38 |
Endothelial Cells - Microvascular, donor1.CNhs11925.11265-116G5 | 202.22 | 33.84 |
Endothelial Cells - Microvascular, donor2.CNhs11376.11342-117G1 | 202.99 | 23.57 |
Endothelial Cells - Microvascular, donor3.CNhs12024.11414-118F1 | 289.21 | 41.98 |
Endothelial Cells - Thoracic, donor1.CNhs11926.11266-116G6 | 117.65 | 20.22 |
Endothelial Cells - Thoracic, donor2.CNhs11978.11343-117G2 | 280.31 | 37.27 |
Endothelial Cells - Umbilical vein, donor1.CNhs10872.11243-116E1 | 82.87 | 17.50 |
Endothelial Cells - Umbilical vein, donor2.CNhs11967.11324-117E1 | 115.86 | 20.43 |
Endothelial Cells - Umbilical vein, donor3.CNhs12010.11400-118D5 | 102.81 | 18.24 |
Endothelial Cells - Vein, donor1.CNhs12497.11267-116G7 | 395.56 | 45.99 |
Endothelial Cells - Vein, donor2.CNhs11377.11344-117G3 | 309.46 | 34.17 |
Endothelial Cells - Vein, donor3.CNhs12026.11416-118F3 | 230.83 | 36.09 |
Eosinophils, donor2.CNhs12548.12245-129H4 | 88.29 | 11.86 |
Eosinophils, donor3.CNhs12549.12246-129H5 | 124.09 | 15.51 |
Esophageal Epithelial Cells, donor1.CNhs11323.11507-119G4 | 219.36 | 27.47 |
Ewing's sarcoma cell line:Hs 863.T.CNhs11836.10705-109H3 | 154.56 | 22.86 |
Fibroblast - Aortic Adventitial, donor1.CNhs10874.11245-116E3 | 121.19 | 12.41 |
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction).CNhs12581.14332-155F3 | 105.79 | 11.52 |
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction).CNhs12400.14311-155C9 | 92.36 | 13.77 |
Fibroblast - Aortic Adventitial, donor3.CNhs12011.11401-118D6 | 152.15 | 25.89 |
Fibroblast - Cardiac, donor1.CNhs12498.11268-116G8 | 216.42 | 25.23 |
Fibroblast - Cardiac, donor2.CNhs11378.11345-117G4 | 352.27 | 36.29 |
Fibroblast - Cardiac, donor3.CNhs12027.11417-118F4 | 279.72 | 40.45 |
Fibroblast - Cardiac, donor4.CNhs11909.11452-119A3 | 128.53 | 14.32 |
Fibroblast - Cardiac, donor5.CNhs12057.11456-119A7 | 137.27 | 20.61 |
Fibroblast - Cardiac, donor6.CNhs12061.11460-119B2 | 116.88 | 23.21 |
Fibroblast - Choroid Plexus, donor1.CNhs11319.11492-119E7 | 144.24 | 18.77 |
Fibroblast - Choroid Plexus, donor2.CNhs12344.11572-120E6 | 211.46 | 20.17 |
Fibroblast - Conjunctival, donor1.CNhs11339.11531-120A1 | 217.92 | 23.90 |
Fibroblast - Dermal, donor1.CNhs12499.11269-116G9 | 293.43 | 30.28 |
Fibroblast - Dermal, donor2.CNhs11379.11346-117G5 | 203.66 | 19.40 |
Fibroblast - Dermal, donor3.CNhs12028.11418-118F5 | 255.41 | 29.74 |
Fibroblast - Dermal, donor4.CNhs12052.11450-119A1 | 102.29 | 18.44 |
Fibroblast - Dermal, donor5.CNhs12055.11454-119A5 | 115.42 | 19.75 |
Fibroblast - Dermal, donor6.CNhs12059.11458-119A9 | 97.75 | 15.59 |
Fibroblast - Gingival, donor1.CNhs10866.11237-116D4 | 112.08 | 15.31 |
Fibroblast - Gingival, donor2.CNhs11961.11318-117D4 | 130.82 | 22.85 |
Fibroblast - Gingival, donor3.CNhs12006.11394-118C8 | 176.07 | 21.60 |
Fibroblast - Gingival, donor4 (GFH2).CNhs10848.11222-116B7 | 133.06 | 24.95 |
Fibroblast - Gingival, donor5 (GFH3).CNhs11952.11303-117B7 | 277.68 | 41.79 |
Fibroblast - Lymphatic, donor1.CNhs11322.11506-119G3 | 246.65 | 24.57 |
Fibroblast - Lymphatic, donor3.CNhs12118.11667-122G2 | 610.83 | 66.83 |
Fibroblast - Periodontal Ligament, donor1.CNhs10867.11238-116D5 | 87.20 | 14.31 |
Fibroblast - Periodontal Ligament, donor2.CNhs11962.11319-117D5 | 122.37 | 18.64 |
Fibroblast - Periodontal Ligament, donor3.CNhs11907.11395-118C9 | 74.81 | 9.42 |
Fibroblast - Periodontal Ligament, donor4 (PL29).CNhs12493.11223-116B8 | 157.59 | 25.46 |
Fibroblast - Periodontal Ligament, donor5 (PL30).CNhs11953.11304-117B8 | 201.36 | 26.97 |
Fibroblast - Periodontal Ligament, donor6 (PLH3).CNhs11996.11380-118B3 | 261.41 | 33.65 |
Fibroblast - Pulmonary Artery, donor1.CNhs10878.11250-116E8 | 123.53 | 17.70 |
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction).CNhs12405.14329-155E9 | 68.71 | 12.02 |
Fibroblast - skin dystrophia myotonica, donor1.CNhs11353.11556-120C8 | 139.24 | 12.17 |
Fibroblast - skin dystrophia myotonica, donor2.CNhs11354.11557-120C9 | 122.28 | 12.08 |
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction).CNhs12399.14308-155C6 | 96.03 | 18.31 |
Fibroblast - skin dystrophia myotonica, donor3.CNhs11913.11560-120D3 | 85.74 | 16.28 |
Fibroblast - skin normal, donor1 (nuclear fraction).CNhs12403.14323-155E3 | 89.14 | 17.78 |
Fibroblast - skin normal, donor1.CNhs11351.11553-120C5 | 123.58 | 16.38 |
Fibroblast - skin normal, donor2 (nuclear fraction).CNhs12582.14302-155B9 | 62.28 | 13.33 |
Fibroblast - skin normal, donor2.CNhs11914.11561-120D4 | 84.97 | 13.93 |
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction).CNhs12404.14326-155E6 | 80.27 | 16.66 |
Fibroblast - skin spinal muscular atrophy, donor1.CNhs11074.11555-120C7 | 146.45 | 23.01 |
Fibroblast - skin spinal muscular atrophy, donor2.CNhs11911.11558-120D1 | 123.98 | 17.62 |
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction).CNhs12398.14305-155C3 | 89.11 | 17.75 |
Fibroblast - skin spinal muscular atrophy, donor3.CNhs11912.11559-120D2 | 88.66 | 14.91 |
Fibroblast - skin walker warburg, donor1.CNhs11352.11554-120C6 | 111.91 | 11.53 |
Gingival epithelial cells, donor1 (GEA11).CNhs11061.11221-116B6 | 139.34 | 17.97 |
Gingival epithelial cells, donor2 (GEA14).CNhs11896.11302-117B6 | 95.19 | 12.55 |
Gingival epithelial cells, donor3 (GEA15).CNhs11903.11379-118B2 | 106.40 | 17.50 |
H9 Embryonic Stem cells, biol_rep2 (H9ES-2).CNhs12824.12724-135G6 | 113.80 | 19.15 |
H9 Embryonic Stem cells, biol_rep3 (H9ES-3).CNhs12837.12822-136I5 | 98.73 | 14.71 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0).CNhs12822.12627-134E8 | 126.19 | 21.73 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0).CNhs12825.12725-135G7 | 125.02 | 16.38 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0).CNhs12908.12823-136I6 | 149.12 | 26.24 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3).CNhs13738.13366-143F9 | 157.67 | 15.69 |
Hair Follicle Dermal Papilla Cells, donor1.CNhs12501.11271-116H2 | 255.01 | 21.90 |
Hair Follicle Dermal Papilla Cells, donor2.CNhs11979.11348-117G7 | 304.90 | 45.03 |
Hair Follicle Dermal Papilla Cells, donor3.CNhs12030.11420-118F7 | 285.94 | 64.92 |
Hair Follicle Outer Root Sheath Cells, donor1.CNhs12339.11504-119G1 | 251.69 | 15.79 |
Hair Follicle Outer Root Sheath Cells, donor2.CNhs12347.11584-120F9 | 302.47 | 27.43 |
Hep-2 cells mock treated, biol_rep1.CNhs13479.11898-125E8 | 156.64 | 23.66 |
Hep-2 cells mock treated, biol_rep2.CNhs13500.11899-125E9 | 171.96 | 17.20 |
Hep-2 cells mock treated, biol_rep3.CNhs13501.11900-125F1 | 178.59 | 18.32 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep1.CNhs13477.11890-125D9 | 162.90 | 27.13 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep2.CNhs13496.11891-125E1 | 179.53 | 16.99 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep3.CNhs13497.11892-125E2 | 150.67 | 18.27 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1.CNhs13478.11894-125E4 | 198.34 | 28.85 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2.CNhs13498.11895-125E5 | 180.52 | 18.05 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3.CNhs13499.11896-125E6 | 185.45 | 16.93 |
Hepatic Sinusoidal Endothelial Cells, donor1.CNhs12075.11521-119H9 | 211.85 | 42.07 |
Hepatic Sinusoidal Endothelial Cells, donor2.CNhs12092.11601-120H8 | 314.14 | 43.47 |
Hepatic Stellate Cells (lipocyte), donor1.CNhs11335.11524-119I3 | 163.39 | 18.52 |
Hepatic Stellate Cells (lipocyte), donor2.CNhs12093.11604-120I2 | 326.36 | 33.81 |
Hepatocyte, donor1.CNhs12340.11523-119I2 | 97.60 | 22.82 |
Hepatocyte, donor2.CNhs12349.11603-120I1 | 154.30 | 6.88 |
Hepatocyte, donor3.CNhs12626.11684-122I1 | 102.21 | 14.18 |
Hodgkin's lymphoma cell line:HD-Mar2.CNhs11715.10435-106E3 | 144.80 | 26.05 |
Intestinal epithelial cells (polarized), donor1.CNhs10875.11246-116E4 | 64.32 | 9.35 |
Iris Pigment Epithelial Cells, donor1.CNhs12596.11530-119I9 | 110.66 | 16.13 |
Keratinocyte - epidermal, donor1.CNhs11064.11272-116H3 | 192.72 | 24.80 |
Keratinocyte - epidermal, donor2.CNhs11381.11349-117G8 | 314.72 | 33.72 |
Keratinocyte - epidermal, donor3.CNhs12031.11421-118F8 | 118.83 | 20.31 |
Keratinocyte - oral, donor1.CNhs10879.11251-116E9 | 86.57 | 13.33 |
Keratocytes, donor1.CNhs11337.11527-119I6 | 301.05 | 35.51 |
Keratocytes, donor2.CNhs12095.11607-120I5 | 276.62 | 31.20 |
Lens Epithelial Cells, donor1.CNhs12342.11529-119I8 | 178.97 | 20.21 |
Lens Epithelial Cells, donor2.CNhs12568.11609-120I7 | 135.17 | 17.51 |
Lens Epithelial Cells, donor3.CNhs12572.11690-122I7 | 119.76 | 12.21 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1).CNhs11936.12260-130A1 | 133.54 | 21.22 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1).CNhs13157.12382-131E6 | 183.81 | 25.00 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 ).CNhs13276.12504-133A2 | 128.04 | 17.31 |
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2.CNhs12475.13097-140D1 | 184.12 | 34.77 |
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3.CNhs12703.13163-141B4 | 163.97 | 22.32 |
Macrophage - monocyte derived, donor1.CNhs10861.11232-116C8 | 61.31 | 16.25 |
Macrophage - monocyte derived, donor2.CNhs11899.11313-117C8 | 70.67 | 16.85 |
Macrophage - monocyte derived, donor3.CNhs12003.11389-118C3 | 74.61 | 19.32 |
Mallassez-derived cells, donor1 (MZH3).CNhs12538.12142-128E9 | 113.42 | 22.50 |
Mallassez-derived cells, donor2.CNhs13550.11929-125I3 | 59.30 | 5.38 |
Mallassez-derived cells, donor3.CNhs13551.11930-125I4 | 75.42 | 8.79 |
Mammary Epithelial Cell, donor1.CNhs11077.11273-116H4 | 84.63 | 12.00 |
Mammary Epithelial Cell, donor2.CNhs11382.11350-117G9 | 96.20 | 13.37 |
Mammary Epithelial Cell, donor3.CNhs12032.11422-118F9 | 324.73 | 44.86 |
Mast cell - stimulated, donor1.CNhs11073.11487-119E2 | 13.30 | 0.49 |
Mast cell, donor1.CNhs12566.11563-120D6 | 95.62 | 9.95 |
Mast cell, donor2.CNhs12594.11565-120D8 | 69.25 | 9.95 |
Mast cell, donor3.CNhs12593.11566-120D9 | 63.70 | 12.97 |
Mast cell, donor4.CNhs12592.11567-120E1 | 82.69 | 15.53 |
Melanocyte - dark, donor3.CNhs12570.11663-122F7 | 80.07 | 10.92 |
Melanocyte - light, donor1.CNhs11303.11274-116H5 | 284.20 | 27.50 |
Melanocyte - light, donor2.CNhs11383.11351-117H1 | 423.15 | 51.58 |
Melanocyte - light, donor3.CNhs12033.11423-118G1 | 369.52 | 53.03 |
Melanocyte, donor1 (MC+1).CNhs12816.12641-134G4 | 152.39 | 13.88 |
Melanocyte, donor2 (MC+2).CNhs13156.12739-135I3 | 168.49 | 21.62 |
Melanocyte, donor3 (MC+3).CNhs13406.12837-137B2 | 166.35 | 16.58 |
Meningeal Cells, donor1.CNhs11320.11493-119E8 | 127.49 | 15.47 |
Meningeal Cells, donor2.CNhs12080.11573-120E7 | 156.51 | 27.90 |
Meningeal Cells, donor3.CNhs12731.11654-122E7 | 96.00 | 20.02 |
Mesenchymal Stem Cells - Wharton's Jelly, donor1.CNhs11057.11548-120B9 | 145.17 | 21.20 |
Mesenchymal Stem Cells - adipose, donor1.CNhs11345.11537-120A7 | 2213.89 | 200.29 |
Mesenchymal Stem Cells - adipose, donor3.CNhs12922.11698-123A6 | 204.56 | 18.60 |
Mesenchymal Stem Cells - amniotic membrane, donor1.CNhs11349.11547-120B8 | 121.00 | 15.16 |
Mesenchymal Stem Cells - amniotic membrane, donor2.CNhs12104.11627-122B7 | 206.97 | 22.88 |
Mesenchymal Stem Cells - bone marrow, donor1.CNhs11344.11536-120A6 | 178.24 | 24.43 |
Mesenchymal Stem Cells - bone marrow, donor2.CNhs12100.11616-122A5 | 282.28 | 32.63 |
Mesenchymal Stem Cells - bone marrow, donor3.CNhs12126.11697-123A5 | 213.94 | 29.84 |
Mesenchymal Stem Cells - hepatic, donor2.CNhs12730.11618-122A7 | 124.96 | 20.45 |
Mesenchymal Stem Cells - umbilical, donor1.CNhs11347.11539-120A9 | 342.39 | 25.50 |
Mesenchymal Stem Cells - umbilical, donor3.CNhs12127.11700-123A8 | 218.98 | 24.70 |
Mesenchymal stem cells - adipose, donor0.CNhs10844.11217-116B2 | 132.90 | 15.31 |
Mesenchymal stem cells - hepatic, donor0.CNhs10845.11218-116B3 | 113.37 | 18.84 |
Mesenchymal stem cells - umbilical, donor0.CNhs12492.11214-116A8 | 170.27 | 16.63 |
Mesothelial Cells, donor1.CNhs10850.11247-116E5 | 121.18 | 19.59 |
Mesothelial Cells, donor2.CNhs12197.12156-128G5 | 135.09 | 14.82 |
Mesothelial Cells, donor3.CNhs12012.11402-118D7 | 106.57 | 24.49 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h).CNhs13646.13317-143A5 | 115.54 | 25.54 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h).CNhs13650.13323-143B2 | 92.92 | 15.57 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h).CNhs13639.13311-142I8 | 75.90 | 6.33 |
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1.CNhs11350.11549-120C1 | 143.77 | 17.25 |
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2.CNhs12105.11629-122B9 | 201.01 | 22.97 |
Myoblast differentiation to myotubes, day00, control donor1.CNhs13847.13469-144I4 | 112.68 | 9.98 |
Myoblast, donor1.CNhs10870.11241-116D8 | 170.26 | 13.61 |
Myoblast, donor2.CNhs11965.11322-117D8 | 200.54 | 17.67 |
Myoblast, donor3.CNhs11908.11398-118D3 | 114.42 | 14.86 |
NK T cell leukemia cell line:KHYG-1.CNhs11867.10777-110G3 | 179.34 | 12.22 |
Natural Killer Cells, donor1.CNhs10859.11230-116C6 | 87.28 | 9.46 |
Natural Killer Cells, donor2.CNhs11957.11311-117C6 | 111.91 | 9.70 |
Natural Killer Cells, donor3.CNhs12001.11387-118C1 | 118.59 | 12.19 |
Neural stem cells, donor1.CNhs11063.11275-116H6 | 84.61 | 12.96 |
Neural stem cells, donor2.CNhs11384.11352-117H2 | 57.26 | 7.81 |
Neurons, donor1.CNhs12338.11494-119E9 | 102.07 | 12.37 |
Neurons, donor2.CNhs12726.11574-120E8 | 108.38 | 20.94 |
Neurons, donor3.CNhs13815.11655-122E8 | 104.62 | 17.86 |
Neutrophils, donor1.CNhs10862.11233-116C9 | 80.89 | 17.98 |
Neutrophils, donor2.CNhs11959.11314-117C9 | 161.55 | 41.88 |
Neutrophils, donor3.CNhs11905.11390-118C4 | 79.98 | 22.79 |
Nucleus Pulposus Cell, donor1.CNhs10881.11252-116F1 | 125.27 | 18.28 |
Nucleus Pulposus Cell, donor2.CNhs12019.11409-118E5 | 361.62 | 42.51 |
Nucleus Pulposus Cell, donor3.CNhs12063.11462-119B4 | 253.09 | 32.01 |
Olfactory epithelial cells, donor1.CNhs13816.11933-125I7 | 205.27 | 27.87 |
Olfactory epithelial cells, donor2.CNhs13817.11934-125I8 | 164.33 | 21.05 |
Olfactory epithelial cells, donor3.CNhs13818.11935-125I9 | 193.50 | 30.44 |
Olfactory epithelial cells, donor4.CNhs13819.11936-126A1 | 192.23 | 24.48 |
Osteoblast - differentiated, donor1.CNhs11311.11276-116H7 | 325.02 | 31.60 |
Osteoblast - differentiated, donor2.CNhs11980.11353-117H3 | 573.07 | 40.93 |
Osteoblast - differentiated, donor3.CNhs12035.11425-118G3 | 507.02 | 51.74 |
Osteoblast, donor2.CNhs11385.11354-117H4 | 112.25 | 10.63 |
Osteoblast, donor3.CNhs12036.11426-118G4 | 232.49 | 30.05 |
Pancreatic stromal cells, donor1.CNhs10877.11249-116E7 | 90.88 | 18.85 |
Pericytes, donor1.CNhs11317.11491-119E6 | 366.54 | 47.97 |
Pericytes, donor2.CNhs12079.11571-120E5 | 348.29 | 50.10 |
Peripheral Blood Mononuclear Cells, donor1.CNhs10860.11231-116C7 | 63.27 | 11.58 |
Peripheral Blood Mononuclear Cells, donor2.CNhs11958.11312-117C7 | 91.03 | 14.02 |
Peripheral Blood Mononuclear Cells, donor3.CNhs12002.11388-118C2 | 95.84 | 15.05 |
Placental Epithelial Cells, donor1.CNhs11079.11278-116H9 | 282.82 | 48.50 |
Placental Epithelial Cells, donor2.CNhs11386.11355-117H5 | 331.21 | 39.94 |
Placental Epithelial Cells, donor3.CNhs12037.11427-118G5 | 293.62 | 57.15 |
Preadipocyte - breast, donor1.CNhs11052.11467-119B9 | 204.44 | 23.57 |
Preadipocyte - breast, donor2 (nuclear fraction).CNhs12584.14320-155D9 | 82.41 | 11.20 |
Preadipocyte - breast, donor2.CNhs11971.11328-117E5 | 179.34 | 21.05 |
Preadipocyte - omental, donor1.CNhs11065.11468-119C1 | 147.49 | 23.96 |
Preadipocyte - omental, donor2.CNhs11902.11329-117E6 | 128.95 | 16.89 |
Preadipocyte - omental, donor3.CNhs12013.11403-118D8 | 132.87 | 14.64 |
Preadipocyte - perirenal, donor1.CNhs12065.11469-119C2 | 246.37 | 25.23 |
Preadipocyte - subcutaneous, donor2.CNhs11981.11356-117H6 | 117.97 | 22.67 |
Preadipocyte - subcutaneous, donor3.CNhs12038.11428-118G6 | 187.86 | 28.05 |
Preadipocyte - visceral, donor1.CNhs11082.11280-116I2 | 87.88 | 17.00 |
Preadipocyte - visceral, donor2.CNhs11982.11357-117H7 | 124.62 | 18.69 |
Preadipocyte - visceral, donor3.CNhs12039.11429-118G7 | 137.94 | 25.22 |
Prostate Epithelial Cells (polarized), donor1.CNhs10882.11253-116F2 | 95.12 | 11.60 |
Prostate Epithelial Cells, donor2.CNhs11972.11331-117E8 | 149.98 | 17.44 |
Prostate Epithelial Cells, donor3.CNhs12014.11404-118D9 | 117.31 | 14.27 |
Prostate Stromal Cells, donor1.CNhs10883.11254-116F3 | 110.22 | 14.58 |
Prostate Stromal Cells, donor2.CNhs11973.11332-117E9 | 188.28 | 23.13 |
Prostate Stromal Cells, donor3.CNhs12015.11405-118E1 | 238.12 | 26.36 |
Renal Cortical Epithelial Cells, donor1.CNhs11331.11516-119H4 | 227.40 | 26.62 |
Renal Cortical Epithelial Cells, donor2.CNhs12728.11596-120H3 | 102.51 | 16.87 |
Renal Epithelial Cells, donor1.CNhs11332.11517-119H5 | 376.49 | 50.98 |
Renal Epithelial Cells, donor2.CNhs12088.11597-120H4 | 283.51 | 24.84 |
Renal Epithelial Cells, donor3.CNhs12732.11678-122H4 | 114.42 | 17.73 |
Renal Glomerular Endothelial Cells, donor1.CNhs12074.11514-119H2 | 247.94 | 61.42 |
Renal Glomerular Endothelial Cells, donor2.CNhs12086.11594-120H1 | 203.43 | 37.25 |
Renal Glomerular Endothelial Cells, donor3.CNhs12624.11675-122H1 | 126.09 | 14.25 |
Renal Glomerular Endothelial Cells, donor4.CNhs13080.11783-124B1 | 439.55 | 58.61 |
Renal Mesangial Cells, donor1.CNhs11333.11518-119H6 | 202.40 | 28.18 |
Renal Mesangial Cells, donor3.CNhs12121.11679-122H5 | 350.68 | 51.67 |
Renal Proximal Tubular Epithelial Cell, donor1.CNhs11330.11515-119H3 | 116.99 | 17.59 |
Renal Proximal Tubular Epithelial Cell, donor2.CNhs12087.11595-120H2 | 224.39 | 24.10 |
Renal Proximal Tubular Epithelial Cell, donor3.CNhs12120.11676-122H2 | 196.34 | 28.21 |
Reticulocytes, biol_rep1.CNhs13552.11931-125I5 | 133.97 | 7.02 |
Reticulocytes, biol_rep2.CNhs13553.11932-125I6 | 196.60 | 9.41 |
Retinal Pigment Epithelial Cells, donor0.CNhs10842.11215-116A9 | 189.77 | 29.75 |
Retinal Pigment Epithelial Cells, donor1.CNhs11338.11528-119I7 | 220.10 | 23.29 |
Retinal Pigment Epithelial Cells, donor3.CNhs12733.11689-122I6 | 186.77 | 28.96 |
SABiosciences XpressRef Human Universal Total RNA, pool1.CNhs10610.10002-101A5 | 51.11 | 12.16 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0).CNhs12859.12760-136B6 | 68.77 | 15.84 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0).CNhs12952.12858-137D5 | 67.08 | 13.94 |
Sebocyte, donor1.CNhs10847.11220-116B5 | 83.84 | 17.80 |
Sebocyte, donor2.CNhs11951.11301-117B5 | 156.66 | 19.50 |
Sertoli Cells, donor1.CNhs10851.11255-116F4 | 118.91 | 20.89 |
Skeletal Muscle Cells, donor1.CNhs11083.11281-116I3 | 239.07 | 31.32 |
Skeletal Muscle Cells, donor4.CNhs12053.11451-119A2 | 139.57 | 23.42 |
Skeletal Muscle Cells, donor5.CNhs12056.11455-119A6 | 151.20 | 25.94 |
Skeletal Muscle Cells, donor6.CNhs12060.11459-119B1 | 116.47 | 19.30 |
Skeletal Muscle Satellite Cells, donor1.CNhs10869.11240-116D7 | 130.52 | 20.30 |
Skeletal Muscle Satellite Cells, donor2.CNhs11964.11321-117D7 | 182.29 | 21.03 |
Skeletal Muscle Satellite Cells, donor3.CNhs12008.11397-118D2 | 138.15 | 21.22 |
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1.CNhs11084.11282-116I4 | 151.98 | 24.39 |
Small Airway Epithelial Cells, donor1.CNhs10884.11256-116F5 | 94.71 | 16.69 |
Small Airway Epithelial Cells, donor2.CNhs11975.11334-117F2 | 123.39 | 19.99 |
Small Airway Epithelial Cells, donor3 (nuclear fraction).CNhs12583.14317-155D6 | 65.85 | 10.46 |
Small Airway Epithelial Cells, donor3.CNhs12016.11406-118E2 | 128.57 | 24.28 |
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction).CNhs12401.14313-155D2 | 281.70 | 25.10 |
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction).CNhs12402.14314-155D3 | 86.26 | 17.00 |
Smooth Muscle Cells - Aortic, donor0.CNhs10838.11210-116A4 | 206.32 | 34.15 |
Smooth Muscle Cells - Aortic, donor1.CNhs11085.11283-116I5 | 164.49 | 21.56 |
Smooth Muscle Cells - Aortic, donor2.CNhs11305.11360-117I1 | 254.97 | 27.68 |
Smooth Muscle Cells - Aortic, donor3.CNhs11309.11432-118H1 | 260.11 | 30.45 |
Smooth Muscle Cells - Brachiocephalic, donor1.CNhs11086.11284-116I6 | 237.59 | 31.51 |
Smooth Muscle Cells - Brachiocephalic, donor3.CNhs12043.11433-118H2 | 187.49 | 16.17 |
Smooth Muscle Cells - Brain Vascular, donor1.CNhs10863.11234-116D1 | 141.05 | 23.45 |
Smooth Muscle Cells - Brain Vascular, donor2.CNhs11900.11315-117D1 | 129.40 | 16.77 |
Smooth Muscle Cells - Brain Vascular, donor3.CNhs12004.11391-118C5 | 172.52 | 23.83 |
Smooth Muscle Cells - Bronchial, donor1.CNhs11328.11512-119G9 | 353.39 | 37.36 |
Smooth Muscle Cells - Bronchial, donor2.CNhs12348.11592-120G8 | 255.05 | 23.54 |
Smooth Muscle Cells - Carotid, donor1.CNhs11087.11285-116I7 | 359.25 | 44.23 |
Smooth Muscle Cells - Carotid, donor3.CNhs12044.11434-118H3 | 390.90 | 51.81 |
Smooth Muscle Cells - Colonic, donor1.CNhs10868.11239-116D6 | 132.93 | 24.82 |
Smooth Muscle Cells - Colonic, donor2.CNhs11963.11320-117D6 | 157.58 | 25.26 |
Smooth Muscle Cells - Colonic, donor3.CNhs12007.11396-118D1 | 148.44 | 23.09 |
Smooth Muscle Cells - Coronary Artery, donor1.CNhs11088.11286-116I8 | 268.30 | 30.13 |
Smooth Muscle Cells - Coronary Artery, donor2.CNhs11987.11363-117I4 | 435.90 | 31.70 |
Smooth Muscle Cells - Coronary Artery, donor3.CNhs12045.11435-118H4 | 209.79 | 27.38 |
Smooth Muscle Cells - Esophageal, donor1.CNhs11324.11508-119G5 | 251.62 | 33.16 |
Smooth Muscle Cells - Internal Thoracic Artery, donor2.CNhs11988.11364-117I5 | 140.38 | 17.55 |
Smooth Muscle Cells - Internal Thoracic Artery, donor3.CNhs12046.11436-118H5 | 401.47 | 32.75 |
Smooth Muscle Cells - Prostate, donor1.CNhs11920.11257-116F6 | 121.48 | 21.98 |
Smooth Muscle Cells - Prostate, donor2.CNhs11976.11335-117F3 | 202.35 | 29.55 |
Smooth Muscle Cells - Pulmonary Artery, donor2.CNhs11989.11365-117I6 | 361.63 | 46.33 |
Smooth Muscle Cells - Subclavian Artery, donor1.CNhs11090.11289-117A2 | 331.37 | 44.66 |
Smooth Muscle Cells - Subclavian Artery, donor2.CNhs11990.11366-117I7 | 264.71 | 20.57 |
Smooth Muscle Cells - Subclavian Artery, donor3.CNhs12048.11438-118H7 | 227.12 | 33.76 |
Smooth Muscle Cells - Tracheal, donor1.CNhs11329.11513-119H1 | 272.02 | 23.73 |
Smooth Muscle Cells - Tracheal, donor3.CNhs12894.11674-122G9 | 194.14 | 24.92 |
Smooth Muscle Cells - Umbilical Artery, donor1.CNhs11091.11290-117A3 | 242.68 | 32.06 |
Smooth Muscle Cells - Umbilical Artery, donor2.CNhs11991.11367-117I8 | 240.42 | 29.12 |
Smooth Muscle Cells - Umbilical Artery, donor3.CNhs12049.11439-118H8 | 278.60 | 43.66 |
Smooth Muscle Cells - Umbilical Vein, donor1.CNhs12597.11541-120B2 | 82.89 | 12.76 |
Smooth Muscle Cells - Umbilical Vein, donor2.CNhs12569.11621-122B1 | 153.76 | 20.53 |
Smooth Muscle Cells - Umbilical artery, donor0.CNhs10839.11212-116A6 | 212.58 | 28.53 |
Smooth Muscle Cells - Uterine, donor3.CNhs11927.11466-119B8 | 149.35 | 23.77 |
Synoviocyte, donor2.CNhs11992.11368-117I9 | 325.32 | 32.51 |
Synoviocyte, donor3.CNhs12050.11440-118H9 | 336.54 | 45.11 |
Trabecular Meshwork Cells, donor1.CNhs11340.11532-120A2 | 166.21 | 25.42 |
Trabecular Meshwork Cells, donor3.CNhs12124.11693-123A1 | 267.35 | 46.19 |
Tracheal Epithelial Cells, donor1.CNhs11092.11292-117A5 | 152.13 | 23.09 |
Tracheal Epithelial Cells, donor2.CNhs11993.11369-118A1 | 359.95 | 35.53 |
Tracheal Epithelial Cells, donor3.CNhs12051.11441-118I1 | 378.94 | 43.56 |
Universal RNA - Human Normal Tissues Biochain, pool1.CNhs10612.10007-101B4 | 51.03 | 14.97 |
Urothelial Cells, donor1.CNhs11334.11520-119H8 | 171.77 | 28.84 |
Urothelial Cells, donor2.CNhs12091.11600-120H7 | 254.39 | 21.90 |
Urothelial Cells, donor3.CNhs12122.11681-122H7 | 261.62 | 38.13 |
Urothelial cells, donor0.CNhs10843.11216-116B1 | 91.20 | 21.36 |
Whole blood (ribopure), donor090309, donation1.CNhs11675.12179-129A1 | 160.86 | 12.18 |
Whole blood (ribopure), donor090309, donation2.CNhs11671.12180-129A2 | 152.93 | 13.00 |
Whole blood (ribopure), donor090309, donation3.CNhs11948.12181-129A3 | 199.38 | 16.52 |
Whole blood (ribopure), donor090325, donation1.CNhs11075.12176-128I7 | 120.78 | 18.82 |
Whole blood (ribopure), donor090325, donation2.CNhs11076.12177-128I8 | 143.15 | 20.57 |
Whole blood (ribopure), donor090612, donation1.CNhs11672.12182-129A4 | 170.55 | 14.27 |
Whole blood (ribopure), donor090612, donation2.CNhs11673.12183-129A5 | 145.27 | 13.50 |
Whole blood (ribopure), donor090612, donation3.CNhs11949.12184-129A6 | 203.83 | 23.00 |
Wilms' tumor cell line:G-401.CNhs11892.10809-111A8 | 129.26 | 15.60 |
Wilms' tumor cell line:HFWT.CNhs11728.10597-108E3 | 154.96 | 19.25 |
acantholytic squamous carcinoma cell line:HCC1806.CNhs11844.10717-109I6 | 108.31 | 23.03 |
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1.CNhs11251.10455-106G5 | 93.09 | 12.45 |
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6.CNhs11282.10534-107G3 | 59.01 | 14.43 |
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL.CNhs10746.10429-106D6 | 99.81 | 18.99 |
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat.CNhs11253.10464-106H5 | 84.02 | 15.94 |
acute myeloid leukemia (FAB M0) cell line:KG-1.CNhs13053.10827-111C8 | 85.02 | 9.98 |
acute myeloid leukemia (FAB M0) cell line:Kasumi-3.CNhs13241.10789-110H6 | 119.31 | 20.68 |
acute myeloid leukemia (FAB M1) cell line:HYT-1.CNhs13054.10828-111C9 | 227.34 | 17.36 |
acute myeloid leukemia (FAB M2) cell line:Kasumi-1.CNhs13502.10788-110H5 | 109.40 | 15.58 |
acute myeloid leukemia (FAB M2) cell line:Kasumi-6.CNhs13052.10792-110H9 | 68.80 | 14.88 |
acute myeloid leukemia (FAB M2) cell line:NKM-1.CNhs11864.10765-110E9 | 94.03 | 12.78 |
acute myeloid leukemia (FAB M3) cell line:HL60.CNhs13055.10829-111D1 | 81.16 | 10.18 |
acute myeloid leukemia (FAB M4) cell line:FKH-1.CNhs13503.10830-111D2 | 97.75 | 7.52 |
acute myeloid leukemia (FAB M4) cell line:HNT-34.CNhs13504.10831-111D3 | 101.41 | 9.82 |
acute myeloid leukemia (FAB M4eo) cell line:EoL-1.CNhs13056.10832-111D4 | 101.49 | 16.70 |
acute myeloid leukemia (FAB M4eo) cell line:EoL-3.CNhs13057.10833-111D5 | 91.42 | 13.52 |
acute myeloid leukemia (FAB M5) cell line:NOMO-1.CNhs13050.10764-110E8 | 95.39 | 16.61 |
acute myeloid leukemia (FAB M5) cell line:P31/FUJ.CNhs13051.10770-110F5 | 104.43 | 14.77 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh).CNhs10722.10399-106A3 | 47.32 | 16.28 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived).CNhs10723.10400-106A4 | 48.54 | 17.00 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed).CNhs10724.10405-106A9 | 57.40 | 16.85 |
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4.CNhs13058.10834-111D6 | 87.73 | 13.09 |
acute myeloid leukemia (FAB M6) cell line:EEB.CNhs13059.10835-111D7 | 101.06 | 7.52 |
acute myeloid leukemia (FAB M6) cell line:F-36E.CNhs13060.10836-111D8 | 161.24 | 20.92 |
acute myeloid leukemia (FAB M6) cell line:F-36P.CNhs13505.10837-111D9 | 233.94 | 20.83 |
acute myeloid leukemia (FAB M7) cell line:M-MOK.CNhs13049.10699-109G6 | 62.62 | 13.66 |
acute myeloid leukemia (FAB M7) cell line:MKPL-1.CNhs11888.10802-111A1 | 59.21 | 4.23 |
adenocarcinoma cell line:IM95m.CNhs11882.10796-110I4 | 85.71 | 18.53 |
adipose tissue, adult, pool1.CNhs10615.10010-101C1 | 51.13 | 16.85 |
adrenal cortex adenocarcinoma cell line:SW-13.CNhs11893.10810-111A9 | 83.13 | 20.51 |
adult T-cell leukemia cell line:ATN-1.CNhs10738.10421-106C7 | 74.67 | 13.71 |
alveolar cell carcinoma cell line:SW 1573.CNhs11838.10708-109H6 | 146.61 | 27.28 |
amniotic membrane cells, donor1.CNhs12502.12235-129G3 | 78.07 | 16.23 |
amniotic membrane cells, donor2.CNhs12503.12236-129G4 | 98.59 | 14.25 |
amniotic membrane cells, donor3.CNhs12379.12237-129G5 | 72.80 | 20.27 |
amygdala - adult, donor10196.CNhs13793.10167-103B5 | 67.60 | 2.98 |
amygdala, adult, donor10252.CNhs12311.10151-102I7 | 81.87 | 13.50 |
anaplastic carcinoma cell line:8305C.CNhs10745.10428-106D5 | 79.70 | 19.15 |
anaplastic large cell lymphoma cell line:Ki-JK.CNhs11881.10795-110I3 | 177.66 | 18.13 |
anaplastic squamous cell carcinoma cell line:RPMI 2650.CNhs11889.10805-111A4 | 109.57 | 15.41 |
aorta, adult, pool1.CNhs11760.10052-101G7 | 60.37 | 12.15 |
appendix, adult.CNhs12842.10189-103D9 | 84.27 | 18.23 |
argyrophil small cell carcinoma cell line:TC-YIK.CNhs11725.10589-108D4 | 82.38 | 19.40 |
astrocytoma cell line:TM-31.CNhs10742.10425-106D2 | 59.42 | 11.25 |
b cell line:RPMI1788.CNhs10744.10427-106D4 | 97.36 | 19.45 |
basal cell carcinoma cell line:TE 354.T.CNhs11932.10702-109G9 | 138.72 | 15.24 |
bile duct carcinoma cell line:HuCCT1.CNhs10750.10432-106D9 | 82.86 | 20.31 |
bile duct carcinoma cell line:TFK-1.CNhs11265.10496-107C1 | 40.64 | 10.74 |
biphenotypic B myelomonocytic leukemia cell line:MV-4-11.CNhs11845.10718-109I7 | 206.68 | 29.67 |
bladder, adult, pool1.CNhs10616.10011-101C2 | 46.86 | 14.01 |
blood, adult, pool1.CNhs11761.10053-101G8 | 160.45 | 33.53 |
bone marrow stromal cell line:StromaNKtert.CNhs11931.10686-109F2 | 278.95 | 16.67 |
brain, adult, donor1.CNhs11796.10084-102B3 | 134.74 | 27.14 |
brain, adult, pool1.CNhs10617.10012-101C3 | 86.27 | 17.35 |
brain, fetal, pool1.CNhs11797.10085-102B4 | 131.75 | 25.95 |
breast carcinoma cell line:MCF7.CNhs11943.10482-107A5 | 90.37 | 15.10 |
breast carcinoma cell line:MDA-MB-453.CNhs10736.10419-106C5 | 43.38 | 17.93 |
breast, adult, donor1.CNhs11792.10080-102A8 | 89.90 | 15.22 |
bronchial squamous cell carcinoma cell line:KNS-62.CNhs11862.10760-110E4 | 88.53 | 12.52 |
bronchioalveolar carcinoma cell line:NCI-H358.CNhs11840.10709-109H7 | 42.71 | 10.42 |
bronchogenic carcinoma cell line:ChaGo-K-1.CNhs11841.10710-109H8 | 46.10 | 11.58 |
carcinoid cell line:NCI-H1770.CNhs11834.10703-109H1 | 77.22 | 19.31 |
carcinoid cell line:SK-PN-DW.CNhs11846.10719-109I8 | 103.81 | 16.04 |
carcinosarcoma cell line:JHUCS-1.CNhs11747.10642-109A3 | 79.35 | 14.93 |
caudate nucleus - adult, donor10196.CNhs13802.10177-103C6 | 53.14 | 8.86 |
caudate nucleus, adult, donor10252.CNhs12321.10164-103B2 | 69.58 | 12.78 |
cerebellum - adult, donor10196.CNhs13799.10173-103C2 | 68.66 | 4.58 |
cerebellum, adult, donor10252.CNhs12323.10166-103B4 | 83.05 | 12.38 |
cerebellum, adult, pool1.CNhs11795.10083-102B2 | 106.10 | 18.62 |
cerebral meninges, adult.CNhs12840.10188-103D8 | 82.93 | 19.96 |
cervical cancer cell line:D98-AH2.CNhs11288.10552-107I3 | 131.71 | 22.66 |
cervical cancer cell line:ME-180.CNhs11289.10553-107I4 | 100.80 | 16.17 |
cervix, adult, pool1.CNhs10618.10013-101C4 | 57.94 | 16.16 |
cholangiocellular carcinoma cell line:HuH-28.CNhs11283.10536-107G5 | 115.99 | 20.97 |
choriocarcinoma cell line:T3M-3.CNhs11820.10618-108G6 | 51.65 | 8.99 |
choriocarcinoma cell line:BeWo.CNhs10740.10423-106C9 | 68.66 | 15.44 |
choriocarcinoma cell line:SCH.CNhs11875.10785-110H2 | 52.69 | 9.78 |
chorionic membrane cells, donor1.CNhs12504.12238-129G6 | 67.63 | 10.85 |
chorionic membrane cells, donor2.CNhs12506.12239-129G7 | 97.37 | 17.50 |
chorionic membrane cells, donor3.CNhs12380.12240-129G8 | 57.57 | 14.92 |
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3.CNhs11714.10416-106C2 | 216.65 | 10.22 |
chronic myeloblastic leukemia (CML) cell line:KCL-22.CNhs11886.10801-110I9 | 74.25 | 12.87 |
chronic myelogenous leukemia (CML) cell line:MEG-A2.CNhs11865.10766-110F1 | 65.15 | 4.16 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1.CNhs12334.10824-111C5 | 85.28 | 11.28 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2.CNhs12335.10825-111C6 | 76.66 | 10.59 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3.CNhs12336.10826-111C7 | 72.67 | 12.75 |
chronic myelogenous leukemia cell line:K562.CNhs11250.10454-106G4 | 58.06 | 14.99 |
chronic myelogenous leukemia cell line:KU812.CNhs10727.10409-106B4 | 141.14 | 11.92 |
clear cell carcinoma cell line:JHOC-5.CNhs11745.10638-108I8 | 58.87 | 21.52 |
clear cell carcinoma cell line:TEN.CNhs11930.10636-108I6 | 98.92 | 30.52 |
colon carcinoma cell line:CACO-2.CNhs11280.10513-107D9 | 65.45 | 10.18 |
colon carcinoma cell line:COLO-320.CNhs10737.10420-106C6 | 48.04 | 17.53 |
colon, adult, donor1.CNhs11794.10082-102B1 | 141.33 | 28.86 |
colon, adult, pool1.CNhs10619.10014-101C5 | 115.88 | 17.16 |
colon, fetal, donor1.CNhs11780.10070-101I7 | 99.60 | 13.44 |
cord blood derived cell line:COBL-a 24h infection(-C).CNhs11049.10452-106G2 | 69.68 | 14.23 |
cord blood derived cell line:COBL-a 24h infection.CNhs11050.10453-106G3 | 68.58 | 15.94 |
cord blood derived cell line:COBL-a untreated.CNhs11045.10449-106F8 | 60.77 | 15.04 |
corpus callosum, adult, pool1.CNhs10649.10042-101F6 | 67.13 | 17.32 |
diaphragm, fetal, donor1.CNhs11779.10069-101I6 | 92.30 | 28.89 |
diencephalon, adult.CNhs12610.10193-103E4 | 97.92 | 15.46 |
diffuse large B-cell lymphoma cell line:CTB-1.CNhs11741.10631-108I1 | 84.84 | 11.86 |
ductal cell carcinoma cell line:KLM-1.CNhs11100.10438-106E6 | 63.20 | 13.31 |
ductal cell carcinoma cell line:MIA Paca2.CNhs11259.10488-107B2 | 280.65 | 12.14 |
ductus deferens, adult.CNhs12846.10196-103E7 | 73.00 | 19.73 |
duodenum, fetal, donor1, tech_rep1.CNhs11781.10071-101I8 | 124.62 | 21.78 |
temporal lobe, fetal, donor1, tech_rep2.CNhs12996.10063-101H9 | 122.12 | 17.75 |
dura mater, adult, donor1.CNhs10648.10041-101F5 | 61.48 | 12.64 |
embryonic kidney cell line: HEK293/SLAM infection, 24hr.CNhs11047.10451-106G1 | 171.97 | 10.52 |
embryonic kidney cell line: HEK293/SLAM untreated.CNhs11046.10450-106F9 | 166.83 | 17.00 |
embryonic pancreas cell line:1B2C6.CNhs11731.10604-108F1 | 84.41 | 17.28 |
embryonic pancreas cell line:1C3D3.CNhs11732.10605-108F2 | 91.35 | 21.85 |
embryonic pancreas cell line:1C3IKEI.CNhs11733.10606-108F3 | 78.48 | 17.58 |
embryonic pancreas cell line:2C6.CNhs11814.10603-108E9 | 80.05 | 8.36 |
endometrial carcinoma cell line:OMC-2.CNhs11266.10497-107C2 | 27.89 | 4.84 |
endometrial stromal sarcoma cell line:OMC-9.CNhs11249.10448-106F7 | 83.62 | 22.19 |
endometrioid adenocarcinoma cell line:JHUEM-1.CNhs11748.10643-109A4 | 180.16 | 12.15 |
epidermoid carcinoma cell line:A431.CNhs10743.10426-106D3 | 57.62 | 10.09 |
epidermoid carcinoma cell line:Ca Ski.CNhs10748.10431-106D8 | 87.41 | 13.23 |
epididymis, adult.CNhs12847.10197-103E8 | 63.43 | 21.84 |
epithelioid sarcoma cell line:HS-ES-1.CNhs11247.10443-106F2 | 194.00 | 36.29 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1.CNhs12325.10815-111B5 | 101.79 | 18.09 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2.CNhs12326.10816-111B6 | 92.53 | 18.27 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3.CNhs12327.10817-111B7 | 107.16 | 19.38 |
esophagus, adult, pool1.CNhs10620.10015-101C6 | 71.38 | 15.91 |
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS.CNhs10728.10410-106B5 | 91.61 | 25.15 |
eye, fetal, donor1.CNhs11762.10054-101G9 | 87.68 | 20.34 |
fibrosarcoma cell line:HT-1080.CNhs11860.10758-110E2 | 109.22 | 18.77 |
fibrous histiocytoma cell line:GCT TIB-223.CNhs11842.10711-109H9 | 89.42 | 17.09 |
frontal lobe, adult, pool1.CNhs10647.10040-101F4 | 72.05 | 16.52 |
gall bladder carcinoma cell line:TGBC14TKB.CNhs11256.10470-106I2 | 36.57 | 14.47 |
gall bladder carcinoma cell line:TGBC2TKB.CNhs10733.10415-106C1 | 50.50 | 13.71 |
gall bladder, adult.CNhs12848.10198-103E9 | 83.25 | 17.72 |
gastric adenocarcinoma cell line:MKN1.CNhs11737.10614-108G2 | 88.32 | 8.99 |
gastric adenocarcinoma cell line:MKN45.CNhs11819.10612-108F9 | 158.21 | 27.95 |
gastric cancer cell line:AZ521.CNhs11286.10549-107H9 | 102.74 | 18.44 |
gastrointestinal carcinoma cell line:ECC12.CNhs11738.10615-108G3 | 107.76 | 10.64 |
giant cell carcinoma cell line:LU65.CNhs11274.10487-107B1 | 60.21 | 7.49 |
giant cell carcinoma cell line:Lu99B.CNhs10751.10433-106E1 | 107.85 | 19.88 |
glassy cell carcinoma cell line:HOKUG.CNhs11824.10688-109F4 | 36.30 | 10.61 |
glioblastoma cell line:A172, tech_rep2.CNhs11248.10444-106F3 | 91.74 | 22.15 |
glioblastoma cell line:A172.CNhs11185.10444-106F3 | 87.24 | 24.69 |
glioblastoma cell line:T98G.CNhs11272.10485-107A8 | 81.80 | 17.03 |
glioma cell line:GI-1.CNhs10731.10413-106B8 | 107.20 | 19.07 |
globus pallidus - adult, donor10196.CNhs13801.10175-103C4 | 65.45 | 8.41 |
globus pallidus, adult, donor10252.CNhs12319.10161-103A8 | 66.13 | 11.36 |
granulocyte macrophage progenitor, donor1.CNhs12519.12131-128D7 | 136.69 | 44.71 |
granulosa cell tumor cell line:KGN.CNhs11740.10624-108H3 | 76.93 | 16.33 |
hairy cell leukemia cell line:Mo.CNhs11843.10712-109I1 | 116.20 | 13.41 |
heart - mitral valve, adult.CNhs12855.10205-103F7 | 57.25 | 20.67 |
heart - pulmonic valve, adult.CNhs12856.10206-103F8 | 60.73 | 25.21 |
heart - tricuspid valve, adult.CNhs12857.10207-103F9 | 61.02 | 14.36 |
heart, adult, diseased post-infarction, donor1.CNhs11757.10050-101G5 | 86.46 | 21.77 |
heart, adult, diseased, donor1.CNhs11758.10051-101G6 | 103.01 | 28.76 |
heart, adult, pool1.CNhs10621.10016-101C7 | 120.51 | 40.39 |
heart, fetal, pool1.CNhs10653.10046-101G1 | 65.64 | 18.54 |
hepatic mesenchymal tumor cell line:LI90.CNhs11868.10778-110G4 | 104.13 | 14.41 |
hepatoblastoma cell line:HuH-6.CNhs11742.10633-108I3 | 79.22 | 4.66 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1.CNhs12328.10818-111B8 | 95.25 | 11.03 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2.CNhs12329.10819-111B9 | 96.76 | 11.21 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3.CNhs12330.10820-111C1 | 91.53 | 10.85 |
hepatoma cell line:Li-7.CNhs11271.10484-107A7 | 94.79 | 13.98 |
hereditary spherocytic anemia cell line:WIL2-NS.CNhs11891.10808-111A7 | 111.60 | 13.12 |
hippocampus - adult, donor10196.CNhs13795.10169-103B7 | 54.87 | 7.95 |
hippocampus, adult, donor10252.CNhs12312.10153-102I9 | 76.00 | 16.07 |
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2.CNhs13822.13425-144D5 | 146.12 | 25.24 |
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1.CNhs13826.13433-144E4 | 149.51 | 24.76 |
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2.CNhs13839.13437-144E8 | 126.29 | 17.45 |
immature langerhans cells, donor1.CNhs13537.11904-125F5 | 39.82 | 3.82 |
immature langerhans cells, donor2.CNhs13480.11905-125F6 | 55.71 | 13.15 |
insula, adult, pool1.CNhs10646.10039-101F3 | 82.68 | 17.13 |
keratoacanthoma cell line:HKA-1.CNhs11880.10791-110H8 | 95.93 | 15.43 |
kidney, adult, pool1.CNhs10622.10017-101C8 | 53.04 | 13.48 |
kidney, fetal, pool1.CNhs10652.10045-101F9 | 71.39 | 15.68 |
large cell lung carcinoma cell line:IA-LM.CNhs11277.10509-107D5 | 75.50 | 11.72 |
large cell lung carcinoma cell line:NCI-H460.CNhs12806.10839-111E2 | 172.65 | 20.80 |
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF.CNhs11825.10692-109F8 | 71.39 | 21.69 |
left atrium, adult, donor1.CNhs11790.10079-102A7 | 94.34 | 45.74 |
left ventricle, adult, donor1.CNhs11789.10078-102A6 | 111.23 | 33.77 |
leiomyoblastoma cell line:G-402.CNhs11848.10721-110A1 | 279.19 | 18.05 |
leiomyoma cell line:10964C.CNhs11722.10569-108B2 | 200.37 | 19.00 |
leiomyoma cell line:15242A.CNhs11723.10570-108B3 | 190.13 | 17.28 |
leiomyoma cell line:15425.CNhs11724.10571-108B4 | 140.76 | 16.00 |
lens epithelial cell line:SRA 01/04.CNhs11750.10647-109A8 | 136.49 | 28.74 |
leukemia, chronic megakaryoblastic cell line:MEG-01.CNhs11859.10752-110D5 | 66.91 | 4.60 |
liposarcoma cell line:KMLS-1.CNhs11870.10782-110G8 | 125.92 | 17.72 |
liposarcoma cell line:SW 872.CNhs11851.10726-110A6 | 95.86 | 17.00 |
liver, adult, pool1.CNhs10624.10018-101C9 | 101.12 | 16.71 |
liver, fetal, pool1.CNhs11798.10086-102B5 | 135.16 | 30.48 |
locus coeruleus - adult, donor10196.CNhs13808.10182-103D2 | 89.85 | 15.38 |
locus coeruleus, adult, donor10252.CNhs12322.10165-103B3 | 84.63 | 10.71 |
lung adenocarcinoma cell line:A549.CNhs11275.10499-107C4 | 77.67 | 22.93 |
lung adenocarcinoma cell line:PC-14.CNhs10726.10408-106B3 | 42.99 | 9.87 |
lung, adult, pool1.CNhs10625.10019-101D1 | 65.14 | 13.35 |
lung, fetal, donor1.CNhs11680.10068-101I5 | 39.77 | 6.13 |
lung, right lower lobe, adult, donor1.CNhs11786.10075-102A3 | 85.75 | 26.93 |
lymph node, adult, donor1.CNhs11788.10077-102A5 | 120.07 | 29.77 |
lymphangiectasia cell line:DS-1.CNhs11852.10727-110A7 | 74.89 | 10.47 |
lymphoma, malignant, hairy B-cell cell line:MLMA.CNhs11935.10775-110G1 | 64.67 | 10.84 |
malignant trichilemmal cyst cell line:DJM-1.CNhs10730.10412-106B7 | 31.92 | 3.83 |
mature adipocyte, donor1.CNhs12558.12231-129F8 | 57.67 | 23.39 |
mature adipocyte, donor2.CNhs12559.12232-129F9 | 57.16 | 20.06 |
mature adipocyte, donor3.CNhs12560.12233-129G1 | 44.73 | 16.24 |
mature adipocyte, donor4.CNhs12562.12234-129G2 | 37.71 | 13.44 |
maxillary sinus tumor cell line:HSQ-89.CNhs10732.10414-106B9 | 32.98 | 12.56 |
medial frontal gyrus - adult, donor10196.CNhs13796.10170-103B8 | 75.32 | 8.86 |
medial temporal gyrus - adult, donor10196.CNhs13809.10183-103D3 | 71.14 | 18.30 |
medial temporal gyrus, adult, donor10252.CNhs12310.10150-102I6 | 80.75 | 14.15 |
medulla oblongata - adult, donor10196.CNhs13800.10174-103C3 | 54.47 | 8.60 |
medulla oblongata, adult, donor10252.CNhs12315.10155-103A2 | 70.77 | 12.87 |
medulla oblongata, adult, pool1.CNhs10645.10038-101F2 | 71.41 | 16.02 |
medulloblastoma cell line:D283 Med.CNhs12805.10838-111E1 | 118.70 | 14.80 |
medulloblastoma cell line:ONS-76.CNhs11861.10759-110E3 | 122.86 | 17.37 |
melanoma cell line:COLO 679.CNhs11281.10514-107E1 | 101.15 | 19.11 |
melanoma cell line:G-361.CNhs11254.10465-106H6 | 84.50 | 9.13 |
meningioma cell line:HKBMM.CNhs11945.10691-109F7 | 171.04 | 28.47 |
merkel cell carcinoma cell line:MKL-1.CNhs12838.10843-111E6 | 68.38 | 20.14 |
merkel cell carcinoma cell line:MS-1.CNhs12839.10844-111E7 | 76.52 | 19.42 |
mesenchymal precursor cell - adipose, donor1.CNhs12363.11747-123G1 | 151.94 | 21.04 |
mesenchymal precursor cell - adipose, donor2.CNhs12364.11748-123G2 | 223.20 | 26.18 |
mesenchymal precursor cell - adipose, donor3.CNhs12365.11749-123G3 | 192.52 | 18.31 |
mesenchymal precursor cell - bone marrow, donor1.CNhs12366.11750-123G4 | 198.87 | 28.41 |
mesenchymal precursor cell - bone marrow, donor2.CNhs12367.11751-123G5 | 233.20 | 21.13 |
mesenchymal precursor cell - bone marrow, donor3.CNhs13098.11840-124H4 | 215.33 | 12.46 |
mesenchymal precursor cell - cardiac, donor1.CNhs12368.11752-123G6 | 240.74 | 31.58 |
mesenchymal precursor cell - cardiac, donor2.CNhs12369.11753-123G7 | 221.25 | 24.35 |
mesenchymal precursor cell - cardiac, donor3.CNhs12370.11754-123G8 | 138.18 | 22.54 |
mesenchymal precursor cell - cardiac, donor4.CNhs12371.11755-123G9 | 103.79 | 16.86 |
mesenchymal precursor cell - ovarian cancer left ovary, donor1.CNhs12372.11756-123H1 | 87.93 | 14.18 |
mesenchymal precursor cell - ovarian cancer left ovary, donor2.CNhs13092.11833-124G6 | 128.19 | 16.64 |
mesenchymal precursor cell - ovarian cancer left ovary, donor3.CNhs12376.11760-123H5 | 110.70 | 20.34 |
mesenchymal precursor cell - ovarian cancer left ovary, donor4.CNhs13094.11836-124G9 | 117.78 | 17.42 |
mesenchymal precursor cell - ovarian cancer metastasis, donor1.CNhs12374.11758-123H3 | 128.67 | 21.27 |
mesenchymal precursor cell - ovarian cancer metastasis, donor2.CNhs13093.11835-124G8 | 145.57 | 17.22 |
mesenchymal precursor cell - ovarian cancer metastasis, donor3.CNhs12378.11762-123H7 | 128.92 | 32.91 |
mesenchymal precursor cell - ovarian cancer metastasis, donor4.CNhs13097.11838-124H2 | 135.95 | 15.23 |
mesenchymal precursor cell - ovarian cancer right ovary, donor1.CNhs12373.11757-123H2 | 74.05 | 10.17 |
mesenchymal precursor cell - ovarian cancer right ovary, donor2.CNhs12375.11759-123H4 | 115.84 | 19.64 |
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02).CNhs12377.11761-123H6 | 120.84 | 27.39 |
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G).CNhs13507.11842-124H6 | 150.35 | 16.24 |
mesenchymal precursor cell - ovarian cancer right ovary, donor4.CNhs13096.11837-124H1 | 118.63 | 18.71 |
mesenchymal stem cell line:Hu5/E18.CNhs11718.10568-108B1 | 123.21 | 19.20 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2.CNhs13420.13230-141I8 | 233.51 | 17.17 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3.CNhs13421.13231-141I9 | 238.42 | 25.93 |
mesodermal tumor cell line:HIRS-BM.CNhs12191.10696-109G3 | 116.09 | 12.62 |
mesothelioma cell line:ACC-MESO-1.CNhs11263.10493-107B7 | 91.30 | 26.20 |
mesothelioma cell line:ACC-MESO-4.CNhs11264.10494-107B8 | 60.26 | 17.37 |
mesothelioma cell line:Mero-25.CNhs13066.10850-111F4 | 110.14 | 15.66 |
mesothelioma cell line:Mero-41.CNhs13067.10851-111F5 | 125.82 | 28.34 |
mesothelioma cell line:Mero-48a.CNhs13068.10852-111F6 | 109.51 | 13.20 |
mesothelioma cell line:Mero-82.CNhs13069.10853-111F7 | 151.74 | 15.17 |
mesothelioma cell line:Mero-83.CNhs13070.10854-111F8 | 161.54 | 23.10 |
mesothelioma cell line:Mero-84.CNhs13072.10855-111F9 | 120.43 | 26.87 |
mesothelioma cell line:Mero-95.CNhs13073.10856-111G1 | 102.19 | 19.08 |
mesothelioma cell line:NCI-H2052.CNhs13063.10847-111F1 | 162.02 | 19.61 |
mesothelioma cell line:NCI-H226.CNhs13062.10846-111E9 | 136.58 | 20.26 |
mesothelioma cell line:NCI-H2452.CNhs13064.10848-111F2 | 112.18 | 27.88 |
mesothelioma cell line:NCI-H28.CNhs13061.10845-111E8 | 94.30 | 16.66 |
mesothelioma cell line:No36.CNhs13074.10857-111G2 | 213.82 | 30.40 |
mesothelioma cell line:ONE58.CNhs13075.10858-111G3 | 165.60 | 14.89 |
middle temporal gyrus, donor10252.CNhs12316.10156-103A3 | 83.09 | 12.72 |
migratory langerhans cells, donor1.CNhs13535.11901-125F2 | 32.35 | 8.96 |
migratory langerhans cells, donor2.CNhs13536.11902-125F3 | 58.06 | 10.50 |
migratory langerhans cells, donor3.CNhs13547.11903-125F4 | 61.34 | 8.83 |
mixed mullerian tumor cell line:HTMMT.CNhs11944.10689-109F5 | 172.00 | 19.98 |
mucinous adenocarcinoma cell line:JHOM-1.CNhs11752.10648-109A9 | 107.65 | 16.22 |
mucinous cystadenocarcinoma cell line:MCAS.CNhs11873.10784-110H1 | 122.14 | 18.81 |
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162.CNhs11858.10744-110C6 | 115.99 | 19.60 |
myelodysplastic syndrome cell line:SKM-1.CNhs11934.10772-110F7 | 73.83 | 11.10 |
myeloma cell line:PCM6.CNhs11258.10474-106I6 | 251.78 | 17.39 |
myxofibrosarcoma cell line:MFH-ino.CNhs11729.10600-108E6 | 95.34 | 13.62 |
myxofibrosarcoma cell line:NMFH-1.CNhs11821.10684-109E9 | 174.90 | 18.78 |
nasal epithelial cells, donor1, tech_rep1.CNhs12589.12226-129F3 | 155.69 | 19.02 |
nasal epithelial cells, donor2.CNhs12574.12227-129F4 | 118.19 | 8.09 |
neuroblastoma cell line:CHP-134.CNhs11276.10508-107D4 | 81.21 | 15.99 |
neuroblastoma cell line:NB-1.CNhs11284.10539-107G8 | 71.06 | 13.80 |
neuroblastoma cell line:NBsusSR.CNhs11818.10607-108F4 | 145.63 | 19.66 |
neuroblastoma cell line:NH-12.CNhs11811.10555-107I6 | 131.71 | 14.20 |
neuroectodermal tumor cell line:TASK1.CNhs11866.10774-110F9 | 235.93 | 21.90 |
neuroectodermal tumor cell line:FU-RPNT-1.CNhs11744.10637-108I7 | 125.63 | 11.48 |
neuroectodermal tumor cell line:FU-RPNT-2.CNhs11753.10663-109C6 | 109.81 | 16.98 |
neuroepithelioma cell line:SK-N-MC.CNhs11853.10728-110A8 | 145.81 | 17.88 |
neurofibroma cell line:Hs 53.T.CNhs11854.10729-110A9 | 159.96 | 18.13 |
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK.CNhs10747.10430-106D7 | 24.37 | 7.26 |
non-small cell lung cancer cell line:NCI-H1385.CNhs12193.10730-110B1 | 82.46 | 16.01 |
normal embryonic palatal mesenchymal cell line:HEPM.CNhs11894.10813-111B3 | 161.88 | 24.33 |
normal intestinal epithelial cell line:FHs 74 Int.CNhs11950.10812-111B2 | 151.29 | 21.74 |
nucleus accumbens, adult, pool1.CNhs10644.10037-101F1 | 73.67 | 16.96 |
occipital cortex - adult, donor10196.CNhs13798.10172-103C1 | 69.43 | 2.83 |
occipital cortex, adult, donor10252.CNhs12320.10163-103B1 | 75.03 | 12.61 |
occipital lobe, adult, donor1.CNhs11787.10076-102A4 | 94.15 | 23.38 |
occipital lobe, fetal, donor1.CNhs11784.10073-102A1 | 97.05 | 18.91 |
occipital pole, adult, pool1.CNhs10643.10036-101E9 | 109.68 | 23.65 |
olfactory region, adult.CNhs12611.10195-103E6 | 87.04 | 16.95 |
optic nerve, donor1.CNhs13449.10277-104E7 | 121.35 | 22.84 |
oral squamous cell carcinoma cell line:Ca9-22.CNhs10752.10434-106E2 | 133.48 | 14.62 |
oral squamous cell carcinoma cell line:HO-1-u-1.CNhs11287.10550-107I1 | 62.64 | 14.04 |
oral squamous cell carcinoma cell line:HSC-3.CNhs11717.10545-107H5 | 93.73 | 13.94 |
oral squamous cell carcinoma cell line:SAS.CNhs11810.10544-107H4 | 111.37 | 11.67 |
osteoclastoma cell line:Hs 706.T.CNhs11835.10704-109H2 | 164.38 | 31.65 |
osteosarcoma cell line:143B/TK^(-)neo^(R).CNhs11279.10510-107D6 | 73.87 | 16.57 |
osteosarcoma cell line:HS-Os-1.CNhs11290.10558-107I9 | 121.74 | 16.31 |
ovary, adult, pool1.CNhs10626.10020-101D2 | 61.30 | 17.75 |
pagetoid sarcoma cell line:Hs 925.T.CNhs11856.10732-110B3 | 93.39 | 8.67 |
pancreas, adult, donor1.CNhs11756.10049-101G4 | 125.04 | 13.29 |
pancreatic carcinoma cell line:NOR-P1.CNhs11832.10698-109G5 | 126.50 | 22.00 |
papillary adenocarcinoma cell line:8505C.CNhs11716.10437-106E5 | 101.70 | 11.79 |
papillotubular adenocarcinoma cell line:TGBC18TKB.CNhs10734.10417-106C3 | 36.82 | 10.50 |
paracentral gyrus, adult, pool1.CNhs10642.10035-101E8 | 85.16 | 16.75 |
parietal lobe - adult, donor10196.CNhs13797.10171-103B9 | 66.39 | 6.25 |
parietal lobe, adult, donor10252.CNhs12317.10157-103A4 | 86.81 | 12.81 |
parietal lobe, adult, pool1.CNhs10641.10034-101E7 | 84.47 | 18.77 |
parietal lobe, fetal, donor1.CNhs11782.10072-101I9 | 71.65 | 14.77 |
parotid gland, adult.CNhs12849.10199-103F1 | 143.10 | 27.41 |
penis, adult.CNhs12850.10200-103F2 | 91.80 | 17.86 |
peripheral neuroectodermal tumor cell line:KU-SN.CNhs11830.10697-109G4 | 85.83 | 11.78 |
pharyngeal carcinoma cell line:Detroit 562.CNhs11849.10723-110A3 | 65.67 | 13.80 |
pineal gland - adult, donor10196.CNhs13804.10179-103C8 | 71.78 | 10.18 |
pineal gland, adult, donor10252.CNhs12228.10160-103A7 | 66.25 | 14.46 |
pituitary gland - adult, donor10196.CNhs13805.10180-103C9 | 49.16 | 8.50 |
pituitary gland, adult, donor10252.CNhs12229.10162-103A9 | 47.81 | 9.56 |
placenta, adult, pool1.CNhs10627.10021-101D3 | 51.54 | 15.97 |
plasma cell leukemia cell line:ARH-77.CNhs12807.10840-111E3 | 121.69 | 12.33 |
pleomorphic hepatocellular carcinoma cell line:SNU-387.CNhs11933.10706-109H4 | 73.05 | 11.66 |
pons, adult, pool1.CNhs10640.10033-101E6 | 75.99 | 14.27 |
postcentral gyrus, adult, pool1.CNhs10638.10032-101E5 | 103.33 | 20.46 |
prostate cancer cell line:DU145.CNhs11260.10490-107B4 | 78.72 | 19.86 |
prostate cancer cell line:PC-3.CNhs11243.10439-106E7 | 58.95 | 12.68 |
prostate, adult, pool1.CNhs10628.10022-101D4 | 58.63 | 14.44 |
putamen, adult, donor10196.CNhs12324.10176-103C5 | 75.73 | 15.71 |
rectal cancer cell line:TT1TKB.CNhs11255.10469-106I1 | 70.63 | 18.22 |
rectum, fetal, donor1.CNhs11777.10067-101I4 | 70.31 | 9.13 |
renal cell carcinoma cell line:OS-RC-2.CNhs10729.10411-106B6 | 63.48 | 15.55 |
renal cell carcinoma cell line:TUHR10TKB.CNhs11257.10471-106I3 | 27.23 | 4.78 |
retina, adult, pool1.CNhs10636.10030-101E3 | 64.11 | 18.66 |
retinoblastoma cell line:Y79.CNhs11267.10475-106I7 | 114.72 | 18.96 |
rhabdomyosarcoma cell line:KYM-1.CNhs11877.10787-110H4 | 83.46 | 15.69 |
rhabdomyosarcoma cell line:RMS-YM.CNhs11269.10477-106I9 | 80.32 | 11.82 |
sacrococcigeal teratoma cell line:HTST.CNhs11829.10695-109G2 | 177.18 | 16.84 |
salivary acinar cells, donor1.CNhs12810.11771-123I7 | 182.97 | 15.33 |
salivary acinar cells, donor2.CNhs12811.11772-123I8 | 158.43 | 13.49 |
salivary acinar cells, donor3.CNhs12812.11773-123I9 | 113.37 | 9.68 |
salivary gland, adult, pool1.CNhs11677.10093-102C3 | 111.86 | 15.49 |
schwannoma cell line:HS-PSS, tech_rep2.CNhs11245.10442-106F1 | 78.10 | 22.13 |
schwannoma cell line:HS-PSS.CNhs11183.10442-106F1 | 79.25 | 20.62 |
seminal vesicle, adult.CNhs12851.10201-103F3 | 66.90 | 16.94 |
serous adenocarcinoma cell line:JHOS-2.CNhs11746.10639-108I9 | 38.49 | 7.10 |
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1.CNhs13508.11843-124H7 | 189.23 | 20.47 |
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1.CNhs13099.11841-124H5 | 149.06 | 21.02 |
serous cystadenocarcinoma cell line:HTOA.CNhs11827.10693-109F9 | 87.81 | 6.15 |
signet ring carcinoma cell line:Kato III.CNhs10753.10436-106E4 | 45.44 | 10.89 |
signet ring carcinoma cell line:NUGC-4.CNhs11270.10483-107A6 | 55.59 | 10.36 |
skeletal muscle - soleus muscle, donor1.CNhs13454.10282-104F3 | 108.12 | 38.20 |
skeletal muscle, adult, pool1.CNhs10629.10023-101D5 | 128.64 | 58.00 |
skeletal muscle, fetal, donor1.CNhs11776.10066-101I3 | 242.40 | 48.71 |
skin, fetal, donor1.CNhs11774.10065-101I2 | 50.51 | 10.20 |
small cell cervical cancer cell line:HCSC-1.CNhs11885.10800-110I8 | 100.13 | 15.44 |
small cell gastrointestinal carcinoma cell line:ECC10.CNhs11736.10610-108F7 | 45.16 | 2.98 |
small cell lung carcinoma cell line:DMS 144.CNhs12808.10841-111E4 | 42.34 | 16.29 |
small cell lung carcinoma cell line:LK-2.CNhs11285.10541-107H1 | 54.33 | 7.45 |
small cell lung carcinoma cell line:NCI-H82.CNhs12809.10842-111E5 | 70.14 | 9.78 |
small cell lung carcinoma cell line:WA-hT.CNhs11812.10562-108A4 | 52.99 | 4.83 |
small intestine, adult, pool1.CNhs10630.10024-101D6 | 166.93 | 15.67 |
small intestine, fetal, donor1.CNhs11773.10064-101I1 | 168.73 | 18.36 |
small-cell gastrointestinal carcinoma cell line:ECC4.CNhs11734.10609-108F6 | 71.49 | 2.35 |
smooth muscle, adult, pool1.CNhs11755.10048-101G3 | 52.71 | 12.01 |
somatostatinoma cell line:QGP-1.CNhs11869.10781-110G7 | 109.59 | 8.96 |
spinal cord - adult, donor10196.CNhs13807.10181-103D1 | 68.71 | 16.69 |
spinal cord, adult, donor10252.CNhs12227.10159-103A6 | 48.72 | 11.88 |
spinal cord, fetal, donor1.CNhs11764.10056-101H2 | 86.64 | 19.44 |
spindle cell sarcoma cell line:Hs 132.T.CNhs11857.10737-110B8 | 107.90 | 15.46 |
spleen, adult, pool1.CNhs10631.10025-101D7 | 62.78 | 12.69 |
spleen, fetal, pool1.CNhs10651.10044-101F8 | 70.65 | 15.73 |
splenic lymphoma with villous lymphocytes cell line:SLVL.CNhs10741.10424-106D1 | 114.83 | 18.19 |
squamous cell carcinoma cell line:EC-GI-10.CNhs11252.10463-106H4 | 55.17 | 9.46 |
squamous cell carcinoma cell line:T3M-5.CNhs11739.10616-108G4 | 123.87 | 9.88 |
squamous cell lung carcinoma cell line:EBC-1.CNhs11273.10486-107A9 | 50.63 | 8.83 |
stomach, fetal, donor1.CNhs11771.10062-101H8 | 48.20 | 10.96 |
submaxillary gland, adult.CNhs12852.10202-103F4 | 96.33 | 18.81 |
substantia nigra, adult, donor10252.CNhs12318.10158-103A5 | 68.37 | 13.19 |
synovial sarcoma cell line:HS-SY-II.CNhs11244.10441-106E9 | 72.42 | 26.19 |
temporal lobe, adult, pool1.CNhs10637.10031-101E4 | 115.79 | 25.63 |
temporal lobe, fetal, donor1, tech_rep1.CNhs11772.10063-101H9 | 139.63 | 30.54 |
duodenum, fetal, donor1, tech_rep2.CNhs12997.10071-101I8 | 115.86 | 14.28 |
tenocyte, donor1.CNhs12639.11763-123H8 | 214.64 | 15.25 |
tenocyte, donor2.CNhs12640.11765-123I1 | 376.67 | 22.65 |
tenocyte, donor3.CNhs12641.11768-123I4 | 294.62 | 23.79 |
teratocarcinoma cell line:PA-1.CNhs11890.10807-111A6 | 127.55 | 11.48 |
teratocarcinoma cell line:NCC-IT-A3.CNhs11878.10790-110H7 | 69.82 | 10.05 |
teratocarcinoma cell line:NCR-G1.CNhs11884.10798-110I6 | 103.51 | 11.28 |
testicular germ cell embryonal carcinoma cell line:ITO-II.CNhs11876.10786-110H3 | 95.26 | 10.91 |
testicular germ cell embryonal carcinoma cell line:NEC14.CNhs12351.10591-108D6 | 61.99 | 17.90 |
testicular germ cell embryonal carcinoma cell line:NEC15.CNhs12362.10593-108D8 | 178.18 | 19.85 |
testicular germ cell embryonal carcinoma cell line:NEC8.CNhs11726.10590-108D5 | 79.22 | 10.28 |
testis, adult, pool1.CNhs10632.10026-101D8 | 111.55 | 32.58 |
testis, adult, pool2.CNhs12998.10096-102C6 | 138.27 | 28.40 |
thalamus - adult, donor10196.CNhs13794.10168-103B6 | 57.21 | 3.32 |
thalamus, adult, donor10252.CNhs12314.10154-103A1 | 61.96 | 13.03 |
throat, adult.CNhs12858.10209-103G2 | 107.47 | 21.32 |
throat, fetal, donor1.CNhs11770.10061-101H7 | 71.42 | 15.24 |
thymus, adult, pool1.CNhs10633.10027-101D9 | 99.40 | 24.54 |
thymus, fetal, pool1.CNhs10650.10043-101F7 | 76.04 | 15.70 |
thyroid carcinoma cell line:TCO-1.CNhs11872.10783-110G9 | 88.47 | 12.90 |
thyroid, adult, pool1.CNhs10634.10028-101E1 | 68.17 | 14.26 |
thyroid, fetal, donor1.CNhs11769.10060-101H6 | 72.16 | 17.99 |
tongue, adult.CNhs12853.10203-103F5 | 113.43 | 27.65 |
tongue, fetal, donor1.CNhs11768.10059-101H5 | 94.11 | 28.41 |
tonsil, adult, pool1.CNhs10654.10047-101G2 | 78.80 | 15.49 |
trachea, adult, pool1.CNhs10635.10029-101E2 | 71.65 | 14.13 |
trachea, fetal, donor1.CNhs11766.10058-101H4 | 91.48 | 15.64 |
transitional-cell carcinoma cell line:5637.CNhs10735.10418-106C4 | 93.04 | 18.32 |
transitional-cell carcinoma cell line:JMSU1.CNhs11261.10492-107B6 | 171.40 | 26.36 |
tridermal teratoma cell line:HGRT.CNhs11828.10694-109G1 | 104.26 | 15.45 |
tubular adenocarcinoma cell line:SUIT-2.CNhs11883.10797-110I5 | 128.63 | 16.80 |
umbilical cord, fetal, donor1.CNhs11765.10057-101H3 | 100.90 | 32.85 |
uterus, adult, pool1.CNhs11676.10100-102D1 | 57.82 | 12.22 |
uterus, fetal, donor1.CNhs11763.10055-101H1 | 93.99 | 15.87 |
vagina, adult.CNhs12854.10204-103F6 | 75.90 | 27.96 |
vein, adult.CNhs12844.10191-103E2 | 91.38 | 17.51 |
xeroderma pigentosum b cell line:XPL 17.CNhs11813.10563-108A5 | 192.02 | 17.31 |